Trial intelligence / Profile preview

Effect of Melatonin on the Incidence of Agitation and Delirium in Head Injury Patients

IRCT2014071016917N2Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in traumatic brain injury (TBI), delirium and agitation comparing Melatonin with Placebo (2 arms). Primary endpoints: Incidence of agitation and Incidence of delirium. Started Aug 2014; status: completed.

02

Drugs

melatonin
03

Conditions

traumatic brain injury (TBI)deliriumagitation

Beyond the preview

Go deeper on IRCT2014071016917N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014071016917N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call